Page 2 - Compounding Pharmacies News Today

The webinar, scheduled for March 6 at 2pm ET and sponsored by Build My Health, will discuss several topics related to weight management including: an overview of GLP-1 weight loss medication, automation in a subscription-based weight management program, and the rise of provider-to-consumer (PTC) models.

Dublin, Jan. 26, 2024 (GLOBE NEWSWIRE) -- The

Dublin, Jan. 26, 2024 (GLOBE NEWSWIRE) -- The

/PRNewswire/ -- Coherent Market Insights has recently published a report, titled, Flake Graphite Market, by Application (Battery, Lubricant, Refractory, and...

Pharmaceutical company Novo Nordisk is pursuing legal action against two compounding pharmacies for allegedly offering contaminated copycat versions of the drug semaglutide, found in weight-loss medications such as Ozempic and Wegovy. The company said it had conducted tests on the compounded drug being sold from two Florida pharmacies and found one sample from Wells Pharmacy…

Novo Nordisk has sued spas, clinics, and pharmacies over unapproved versions of its Type 2 diabetes drug Ozempic and weight loss therapy Wegovy.

Eli Lilly on Thursday said it sued 11 online pharmacies to stop them from importing, selling and distributing products claiming to contain the active ingredient in its diabetes drug Mounjaro, which is expected to be approved for weight loss later this year. The Indianapolis-based drugmaker said the suit will go to the U.S. International Trade Commission (ITC). It names the U.S.-based Artic Peptides, Strate Labs, Supopeptide, The Triggered Brand, and Unewlife as defendants, along with Britain’s...

After Ozempic was hailed as a miracle for weight loss, other injectable compounds in the same pharmaceutical class are becoming more popular.

Compounding Pharmacies Market 2023 published by Fior Markets put forth a systematic evaluation of the industry and main market trends with historical

Novo Nordisk has filed lawsuits against three compounding pharmacies in Florida for allegedly selling compounded forms of its popular Type 2 diabetes drug Ozempic.